USE OF VOLATILE AGENTS TO DIAGNOSE UROLOGICAL DISEASE
Research type
Research Study
Full title
STUDY OF THE MEASUREMENT OF VOLATILE AGENTS TO DIAGNOSE UROLOGICAL DISEASE
IRAS ID
224760
Contact name
Iain McIntyre
Contact email
Clinicaltrials.gov Identifier
N/A, N/A
Duration of Study in the UK
0 years, 11 months, 31 days
Research summary
Studies have demonstrated that, by sniffing urine samples, dogs are able to identify a higher proportion of bladder and prostate cancer patients than would be expected from chance alone. It is thought that these dogs are able to detect volatile organic compounds in the air above the urine sample. One previous study has suggested that such compounds can be detected by gas chromatography in cancer patients. The aim of the present study is to detect volatile compounds using a ’sensor tab’ suspended above a urine samples taken from patients with untreated bladder cancer, active prostate cancer and from control patients with neither bladder nor prostate cancer. The sensor tab absorbs volatile organic compounds which are then analysed to look for differences between the above three groups of patients. The aspiration of this study is that the ’sensor tab’ might be developed into one of a group of tests to aid in the detection significant bladder or prostate cancer.
REC name
North West - Liverpool Central Research Ethics Committee
REC reference
17/NW/0399
Date of REC Opinion
13 Jul 2017
REC opinion
Favourable Opinion